News - Page 3 of 4

PharmaNL publishes Investment Agenda for Shared Development Infrastructure

January 30, 2025

PharmaNL today publishes the Investment Agenda for the Shared Development Infrastructure program line. This document (part 3) is an integral part of the PharmaNL investment agenda as presented on August 22, 2024, focusing on the Human Capital Growth program line. The Investment Agenda serves as a roadmap for investments aimed at strengthening the Dutch pharmaceutical […]

Wanted: Companies for Pilots in Early Drug Discovery Training

December 18, 2024

Is your company struggling to find well-trained personnel for roles within early drug discovery? Radboud University, HAN University of Applied Sciences, and Elevate, who are running the PharmaNL project Early Drug Discovery Education Track, invite companies to collaborate and participate. This project, part of PharmaNL’s Human Capital Growth program, focuses on developing innovative training programs […]

Submitting a Project Idea for PharmaNL’s Human Capital Growth Program? Here’s What You Need to Know!

December 10, 2024

The deadline to submit project ideas is approaching quickly: Monday, January 13, 2025, at 2:00 PM. “This is a firm deadline,” emphasizes Claudia Leusink, Program Manager for PharmaNL at ZonMw. “Without a submitted project idea, you cannot proceed to submit a full grant application. So, start early!”

From Innovation to Transformation: Meet Floor van de Watering, the New Program Manager of PharmaNL

November 11, 2024

Since October 1, Floor van de Watering has taken on the role of program manager at PharmaNL. With over fifteen years of experience in guiding healthcare innovations to market, her career began as a researcher at Radboudumc, where she worked on injectable bone treatments during her PhD and focused on breast tumor detection in her […]

ZonMw opens the funding call on November 5 as part of the PharmaNL Human Capital Growth program.

November 5, 2024

ZonMw opened a funding call on November 5 as part of the PharmaNL Human Capital Growth program. This call aims to address the prioritized themes in PharmaNL’s investment agenda, providing a sustainable boost to the human capital available to the Dutch pharmaceutical industry.

Nanoworx: A New Step in Nanomedicine

October 25, 2024

How can we better harness the potential of nanomedicine? The new initiative Nanoworx, a Contract Research Organisation (CRO), has been established to automate and accelerate the production of innovative nanomedicines. Thanks to a recent grant from PharmaNL in the Shared Development Infrastructure program line, Nanoworx can produce nanomedicine libraries and identify formulations with the best […]

Meet, get Inspired, and explore opportunities: Join the PharmaNL Connection Days

October 17, 2024

On November 18, November 26, and December 4, 2024, from 3:30 PM to 5:30 PM, PharmaNL and its partners are hosting the PharmaNL Connection Days. These inspiring networking events are designed for meeting peers, obtaining information about new grant rounds within PharmaNL, and gaining inspiration. The PharmaNL Connection Days coincide with the announcement that ZonMW […]

The “PharmaNL Shared Development Infrastructure” project has officially started its funding round.

October 8, 2024

The project “Advancing the Cure: Efficient Screening to Optimize Early-Stage Drug Discovery (ACESO)” will soon commence under the leadership of Judith Rasmussen-Dietvorst, as part of the PharmaNL Shared Development Infrastructure program. This program focuses on creating infrastructure for pharmaceutical products and technologies to advance drug development.

Announcement: New Funding Round for Human Capital Growth PharmaNL

September 30, 2024

ZonMw plans to open the new funding round for the Human Capital Growth program line of PharmaNL on November 5. This call offers opportunities for projects focused on the development and growth of human capital within the pharmaceutical sector. The program aims to stimulate innovation in the pharmaceutical industry and contribute to the further development […]

G2Solutions: Funding for Innovation in Single-Cell Genomics

September 17, 2024

The G2Solutions project, led by Prof. Dr. Ir. Floris Foijer from the UMCG – ERIBA Research Institute, has received funding from PharmaNL under the PharmaNL Shared Development Infrastructure program for their five-year project. G2Solutions focuses on developing infrastructure for new drug development. “This project demonstrates that we can make unique technologies, such as single-cell sequencing […]